down arrow

Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE1000062X2
CNY
63.66
-0.89 (-1.38%)

Dec 05

SHG

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
Why is Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. ?
1
With a growth in Net Profit of 127.57%, the company declared Very Positive results in Mar 25
  • The company has declared positive results for the last 10 consecutive quarters
  • OPERATING CASH FLOW(Y) Highest at CNY 770.67 MM
  • ROCE(HY) Highest at 13.44%
  • RAW MATERIAL COST(Y) Fallen by -4.07% (YoY)
2
With ROE of 12.41%, it has a fair valuation with a 5.76 Price to Book Value
  • Over the past year, while the stock has generated a return of 179.19%, its profits have risen by 131.7%
  • At the current price, the company has a high dividend yield of 0.2
3
Market Beating performance in long term as well as near term
  • Along with generating 179.19% returns in the last 1 year, the stock has outperformed China Shanghai Composite in the last 3 years, 1 year and 3 months
stock-recommendationReal-Time Research Report
Verdict Report
How much should you buy?
  1. Overall Portfolio exposure to Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. for you?

High Risk, High Return

Absolute
Risk Adjusted
Volatility
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
182.93%
2.62
73.33%
China Shanghai Composite
15.19%
1.01
14.58%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
3.98%
EBIT Growth (5y)
4.39%
EBIT to Interest (avg)
22.12
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.23
Sales to Capital Employed (avg)
0.21
Tax Ratio
4.65%
Dividend Payout Ratio
10.77%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
2.47%
ROE (avg)
3.89%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
46
Industry P/E
Price to Book Value
5.76
EV to EBIT
142.65
EV to EBITDA
89.73
EV to Capital Employed
9.77
EV to Sales
24.60
PEG Ratio
NA
Dividend Yield
0.23%
ROCE (Latest)
6.85%
ROE (Latest)
12.41%
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
Bearish
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Bullish
No Trend
OBV
No Trend
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

15What is working for the Company
OPERATING CASH FLOW(Y)

Highest at CNY 770.67 MM

ROCE(HY)

Highest at 13.44%

RAW MATERIAL COST(Y)

Fallen by -4.07% (YoY

NET PROFIT(9M)

Higher at CNY 646.14 MM

-2What is not working for the Company
DEBT-EQUITY RATIO (HY)

Highest at -23.38 %

Here's what is working for Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
Net Profit
At CNY 546.59 MM has Grown at 158.02%
Year on Year (YoY)
MOJO Watch
Near term Net Profit trend is very positive

Net Profit (CNY MM)

Operating Cash Flow
Highest at CNY 770.67 MM and Grown
In each year in the last three years
MOJO Watch
The company has generated higher cash revenues from business operations

Operating Cash Flows (CNY MM)

Net Profit
Higher at CNY 546.59 MM
than preceding 12 month period ended Mar 2025
MOJO Watch
In the half year the company has already crossed Net Profit of the previous twelve months

Net Profit (CNY MM)

Raw Material Cost
Fallen by -4.07% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
Debt-Equity Ratio
Highest at -23.38 % and Grown
In each half year in the last five Semi-Annual periods
MOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."